Caused by HPV, cervical cancer is nearly 100% preventable¹

Introducing the Roche HPV Self-Collection Solution. Learn how you can know now if any woman is at risk for cervical cancer and get in touch with us by clicking the button below.

Introducing the Roche HPV Self Collection Solution

Impact to US women

In the United States in 2019²

• 23% of US women were overdue for cervical cancer screenings compared to 14% in 2005
• 80% of those women were people of color and those that self identified as a racial or ethnic group other than non-Hispanic white
• Over 77% of those women self reported that a lack of knowledge they needed screened, no recommendation from a
  healthcare professional and lack of access were the cause

More than

50%

of all new cervical cancers  are in women who have never  been screened or have not  been screened in the previous  5 years of their lives.⁴

“A major barrier for women across many  cultures has been the requirement to undergo  a speculum examination. With the emergence  of HPV-based primary screening, the option  of self-collection… may overcome this barrier,  given that such samples when tested using  PCR-based HPV assays have similar  sensitivity for the detection of cervical  pre-cancers as practitioner-collected  cervical specimens.”³

Why invest now in HPV self-collection?

Accessibility

• Reduces barriers to testing, especially for those who have difficulty with pelvic exams, such as those with a history of trauma, sexual or gender minority patients, and those with mobility issues⁵ 
• Improves access in hard-to-reach and rural communities with limited transportation options and distant health facilities
• Can be easily incorporated into other health visits

Empowerment

• Patient satisfaction could be higher with self-collection vs clinician collection due to greater convenience, privacy, and access and presents the opportunity for clinicians to interact with patients in an empathetic manner to encourage healthcare management⁶
• Enables women to better manage their own health
• Provides privacy, convenience, ease and comfort of collection

Outcomes

• Improves cervical cancer screening attendance⁷
• Self-collection shows a high correlation with clinician collection emphasizing the reliability and validity of self-collection methods⁸
• Leads to more effective and sustainable access to cervical screening services, enabling detection of pre-cancer and preventing progression of cervical cancer

How does HPV self-collection work?

For more information on collection devices, the Roche HPV self-collection solution and how to get started, have your local support team contact you by filling out the form.

1. Nearly all cervical cancers are preventable with HPV vaccination, routine screening, and appropriate treatment when needed. https://www.cancer.gov/types/cervical/causes-risk-prevention#:~:text=Cervical%20cancer%20is%20preventable,follow%2Dup%20treatment%20when%20needed. Accessed on 01 October 2024

2. National Cancer Institute. Why are many women overdue for cervical cancer screening? https://www.cancer.gov/news-events/cancer-currents-blog/2022/overdue-cervical-cancer-screening-increasing Accessed 08 August 2024

3. Hawkes D, et al. Self-Collection for Cervical Screening Programs: From Research to Reality. Cancers (Basel). 2020 Apr4;12(4):1053.doi: 10.3390/cancers12041053. PMID: 32344565; PMCID: PMC7226191.

4. Subramaniam A, Fauci JM, Schneider KE, Whitworth JM, Erickson BK, Kim K, Huh WK. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era? J Low Genit Tract Dis. 2011 Apr;15(2): 110-3. doi:10.1097/LGT.0b013e3181f515a2. PMID: 21263352; PMCID: PMC4465558

5. Fontenot HB, Fuzzell L, Brownstein NC, et al. Health Care Provider Willingness to Recommend Self-collected Tests for Human Papillomavirus: A Mixed Methods Examination of Associated Factors. Womens Health Issues. Published online July 2, 2024.

6. Danan ER, Amundson EC, Gowdy-Jaehnig A, et al. “It Feels Like Health Care With the Patient in Mind”: VA Patient and Staff Perspectives on Self-Collected HPV Testing. Women’s Health Issues. June 17, 2024. https://pubmed.ncbi.nlm.nih.gov/38890078/ Accessed 09 August 2024.

7. Elfström KM, et al. Increasing participation in cervical screening by targeting long-term nonattenders: Randomised health services study. Int J Cancer.  2019 Dec 

8. Inturrisi F, Aitken CA, Melchers WJG, van den Brule AJC, Molijn A, Hinrichs JWJ, Niesters HGM, Siebers AG, Schuurman R, Heideman DAM, de Kok IMCM, Bekkers RLM, van Kemenade FJ, Berkhof J. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study. Lancet Reg Health Eur. November 9, 2021 http://dx.doi.org/10.1016/j.lanepe.2021.100235 Accessed 09 August 2024.